Answer
Clopidogrel's active metabolite selectively and irreversibly inhibits ADP binding to the platelet P2Y₁₂ receptor, thereby inhibiting platelet aggregation.
Sources for this answer
- Plavix 300mg tabletsSANOFI · emc · SmPC §5.1 Pharmacodynamic properties · Version 25Document updated
Sources checked